Trans Linoleic Fatty Acid is a specific type of trans fat that is measured in the Nutristat Basic Profile by US Biotek. Trans fats, including Trans Linoleic Fatty Acid, are unsaturated fats that have been chemically altered to improve shelf life and stability in foods, but they can have negative health effects.
Measuring Trans Linoleic Fatty Acid Levels
On the Nutristat Basic Profile, measuring Trans Linoleic Fatty Acid levels helps assess an individual's intake of trans fats, which are commonly found in processed and fried foods. High levels of Trans Linoleic Fatty Acid in the body are a concern because they are linked to increased risks of heart disease, inflammation, and other chronic health conditions.
Importance of Trans Linoleic Fatty Acid Monitoring
This marker is important for understanding the impact of dietary choices on overall health. When Trans Linoleic Fatty Acid levels are high, it suggests that a person may be consuming too many unhealthy fats, which could contribute to poor cardiovascular health and metabolic disturbances. Studies have shown that a diet high in trans fats can lead to an increased risk of heart disease, stroke, and type 2 diabetes.
Reducing Trans Linoleic Fatty Acid Intake
By monitoring this marker, healthcare providers can offer personalized dietary recommendations to reduce trans fat intake, promoting better health outcomes. Reducing consumption of foods high in trans fats, such as baked goods, snacks, and certain margarines, can help lower Trans Linoleic Fatty Acid levels and support heart health.In conclusion, Trans Linoleic Fatty Acid is a valuable marker in the Nutristat Basic Profile that provides insights into an individual's intake of unhealthy trans fats. By monitoring and reducing Trans Linoleic Fatty Acid levels through dietary changes, individuals can take proactive steps towards improving cardiovascular health and reducing the risk of chronic diseases associated with trans fat consumption.
References:
- Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006). Trans fatty acids and cardiovascular disease. New England Journal of Medicine, 354(15), 1601-1613. https://doi.org/10.1056/NEJMra054035
- Micha, R., & Mozaffarian, D. (2009). Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nature Reviews Endocrinology, 5(6), 335-344. https://doi.org/10.1038/nrendo.2009.79
- Sacks, F. M., Lichtenstein, A. H., Wu, J. H., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., Stone, N. J., & Van Horn, L. V. (2017). Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation, 136(3), e1-e23. https://doi.org/10.1161/CIR.0000000000000510
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.